Urovalve Bladder Management System Shows Early Promise in Clinical Trial
Urovalve announced promising early results this week in a multi-site clinical trial of its Surinate Bladder Management System.
Urovalve announced promising early results this week in a multi-site clinical trial of its Surinate Bladder Management System.
The mid-year conference’s goal was to bring together a promising group of 75 private and microcap companies in 25 different healthcare sectors with a prominent group of European and U.S. institutional investor groups.
The Surinate Bladder Management system is comprised of a simple magnetically controlled valve that can be activated remotely by a Surinate wearer who uses a hand held magnet to self-regulate flow.
Men with acute or chronic urinary retention find that the condition limits their normal activities, causes embarrassment, and poses serious health risks. Urovalve of Newark, NJ, seeks to replace catheterization with an updated treatment that returns bladder control to the patient.
Copyright © 2024 | WordPress Theme by MH Themes